A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease-Reference-Cited by-同舟云学术

A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease

Published:2005-11 Issue:10 Volume:46 Page:1812-1819
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Leon Martin B.,Kornowski Ran,Downey William E.,Weisz Giora,Baim Donald S.,Bonow Robert O.,Hendel Robert C.,Cohen David J.,Gervino Ernest,Laham Roger,Lembo Nicholas J.,Moses Jeffrey W.,Kuntz Richard E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Direct myocardial revascularization and angiogenesis—how many patients might be eligible?;Mukherjee;Am J Cardiol,1999

2. The transmyocardial laser revascularization international registry report;Burns;Eur Heart J,1999

3. Transmyocardial laser revascularization in the patient with unmanageable unstable angina;Hattler;Ann Thorac Surg,1999

4. End stage coronary disease treated with the transmyocardial CO2laser revascularization;Vincent;Eur J Cardiothorac Surg,1997

5. Transmyocardial laser revascularization;Agarwal;Ann Thorac Surg,1999

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy of Permanent Internal Mammary Artery Occlusion in Chronic Coronary Syndrome: A Double-Blind, Randomized, Sham-Controlled Trial;The American Journal of Cardiology;2024-08

2. Coronary Sinus Reducer Therapy for Refractory Angina and its Role in Modern Interventional Practice: A Contemporary Review;Interventional Cardiology: Reviews, Research, Resources;2024-07-09

3. Placebo Control and Blinding in Randomized Trials of Procedural Interventions;JAMA Surgery;2024-07-01

4. A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial;EuroIntervention;2024-02

5. Health Benefits of Transcatheter Tricuspid Valve Repair;Journal of the American College of Cardiology;2024-01